Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.52 USD | -1.11% | +0.44% | +32.51% |
05-24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
05-21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.51% | 2.83B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Transcript : PTC Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08